...
首页> 外文期刊>Journal of pharmacological sciences. >Retraction: Nuclear receptors as targets for drug development: Crosstalk between peroxisome proliferator-activated receptor γ and cytokines in bone marrow-derived mesenchymal stem cells (Journal of Pharmacological Sciences (2005) 97, (184-189))
【24h】

Retraction: Nuclear receptors as targets for drug development: Crosstalk between peroxisome proliferator-activated receptor γ and cytokines in bone marrow-derived mesenchymal stem cells (Journal of Pharmacological Sciences (2005) 97, (184-189))

机译:收缩:核受体作为药物开发的靶标:过氧化物酶体增殖物激活的受体γ与骨髓间充质干细胞中的细胞因子之间的串扰(药理学杂志(2005)97,(184-189))

获取原文
获取原文并翻译 | 示例

摘要

The following review article by I. Takada, M. Suzawa, and S. Kato: Nuclear receptors as targets for drug development: crosstalk between peroxisome proliferator-activated receptor y and cytokines in bone marrow-derived mesenchymal stem cells. J Pharmcol Sci 97,184-189 (2005) has been retracted by agreement between the authors, the journal Editor in Chief, and The Japanese Pharmacological Society. The authors have requested the retraction based on their acknowledgement that their original article underlying this review is under doubt because of improper figure image arrangements.
机译:I. Takada,M。Suzawa和S. Kato撰写的以下评论文章:核受体作为药物开发的目标:过氧化物酶体增殖物激活的受体y与骨髓间充质干细胞中的细胞因子之间的串扰。根据作者,杂志主编和日本药理学会的同意,J Pharmcol Sci 97,184-189(2005)已撤回。作者之所以要求撤稿,是因为他们承认,由于不正确的人物形象安排,他们对这篇评论所依据的原始文章受到了质疑。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号